发明名称 |
NOVEL SCHEDULES FOR ADMINISTERING COMBINATION THERAPIES USEFUL FOR TREATING PERSONS AFFLICTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS (HIV) |
摘要 |
The invention relates to a pharmaceutical composition for treating the human immunodeficiency virus (HIV) in humans, including three or four active principles selected as: a nucleoside reverse transcriptase inhibitor (NARTI) selected from lamivudine and emtricitabine; a nucleoside or nucleotide reverse transcriptase inhibitor (NARTI) selected from didanosine, abacavir and tenofovir; and the combination of ritonavir with a protease inhibitor (PI) selected from lopinavir, fosamprenavir, atazanavir and darunavir; or an non-nucleoside reverse transcriptase inhibitor (NNRTI) selected from efavirenz and etravirine; for daily administration to said human being one to four days per week. |
申请公布号 |
WO2011061302(A1) |
申请公布日期 |
2011.05.26 |
申请号 |
WO2010EP67851 |
申请日期 |
2010.11.19 |
申请人 |
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS;LEIBOWITCH, JACQUES |
发明人 |
LEIBOWITCH, JACQUES |
分类号 |
A61K31/34;A61K31/426;A61K31/4418;A61K31/505;A61K31/513;A61K31/52;A61K31/536;A61K31/661;A61K31/675;A61K31/7068;A61P31/18 |
主分类号 |
A61K31/34 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|